Mayo Clinic

Investment Strategy

Mayo Clinic is one of the most prestigious nonprofit academic medical centers in the world, managing approximately $15 billion in endowment and investment assets. Founded in Rochester, Minnesota, in the 1880s by Dr. William Worrall Mayo and his sons, Drs. William James Mayo and Charles Horace Mayo, the clinic has grown into a multisite health system with major campuses in Rochester, Phoenix/Scottsdale, and Jacksonville, along with the Mayo Clinic Health System network serving communities across the Upper Midwest.

The endowment supports Mayo Clinic’s three integrated missions: patient care, medical research, and medical education. Unlike most academic medical centers that are affiliated with universities, Mayo Clinic operates independently, and its endowment is managed by the clinic’s own investment team and investment committee. This independence gives the investment team significant flexibility in portfolio construction and manager selection.

The investment portfolio is diversified across public equities, fixed income, private equity, venture capital, hedge funds, and real estate. At $15 billion, the endowment is large enough to access institutional-quality investment opportunities across all asset classes, including direct investments and co-investment programs. The portfolio’s construction reflects a perpetual investment horizon, with meaningful allocations to illiquid strategies that can generate premium returns over long time periods.

Mayo Clinic’s endowment has benefited from the clinic’s strong financial position and consistent philanthropic support. The clinic receives significant annual donations from grateful patients and supporters, which supplement the endowment alongside investment returns. The combined financial resources support Mayo Clinic’s substantial capital expenditure program, including ongoing investments in facilities, technology, and research infrastructure.

Private Markets Approach

Mayo Clinic allocates a significant portion of its endowment to private equity, venture capital, hedge funds, and real estate. The alternatives allocation, estimated at approximately 35% of total assets, reflects the endowment’s scale and perpetual time horizon, which support meaningful exposure to illiquid strategies.

The private equity program includes commitments to buyout, growth equity, and venture capital funds. Mayo Clinic’s position as a leading health care institution gives its investment team differentiated insight into health care and life sciences investment opportunities. While the endowment is managed as a diversified portfolio across all sectors, the clinic’s institutional knowledge in medicine, medical devices, pharmaceuticals, and health care delivery provides natural expertise for evaluating health care-related private equity and venture strategies.

Mayo Clinic has also been active in health care venture capital, both through fund commitments and through Mayo Clinic Ventures, the clinic’s technology commercialization arm. Mayo Clinic Ventures manages a portfolio of intellectual property and technology licenses derived from the clinic’s research programs, providing an additional dimension of private markets engagement beyond the endowment’s fund investment program.

Real estate represents a meaningful component of the alternatives allocation, given Mayo Clinic’s extensive physical campus infrastructure and its ongoing capital expansion programs. The endowment’s real estate investments include institutional fund commitments alongside the clinic’s direct real estate holdings.

Hedge fund allocations provide diversification and alternative return sources within the portfolio. The endowment’s scale supports a multi-strategy hedge fund program that can access a range of absolute return, long-short equity, and macro strategies.

Fund managers seeking commitments should understand that Mayo Clinic evaluates opportunities with the rigor of a large institutional investor. The investment team assesses track record, strategy differentiation, risk management, and alignment with the portfolio’s objectives. Managers in health care, life sciences, and medical technology sectors may find particular interest given the clinic’s domain expertise, but strong managers across all sectors are relevant to the endowment’s diversified allocation.